Corpus Intelligence IC Memo — MCHS-RED CEDAR 2026-04-26 05:27 UTC
IC Memo — MCHS-RED CEDAR
Investment Committee Memorandum | WI | 25 beds | Grade B | EBITDA uplift $9.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MCHS-RED CEDAR

CCN 521340 | DUNN, WI | 25 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

MCHS-RED CEDAR is a 25-bed suburban community hospital in DUNN, WI with $123.4M in net patient revenue and a 16.8% operating margin. The hospital serves a payer mix of 57.3% Medicare, 9.2% Medicaid, and 33.6% commercial.

Thesis: Turnaround. Our ML models identify $9.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 16.8% to 24.2% (+736bps).

Net Revenue HCRIS$123.4M
Current EBITDA COMPUTED$20.7M
Operating Margin COMPUTED16.8%
Occupancy HCRIS64.8%
Revenue / Bed COMPUTED$4.9M
Net-to-Gross HCRIS47.3%
Distress Probability ML43.4%

2. Market Context & Competitive Position

150
WI Hospitals
0.4%
State Median Margin
87
Comparable Hospitals

WI has 150 Medicare-certified hospitals with a median operating margin of 0.4%. The target's margin of 16.8% places it above the state median. Among 87 size-comparable peers (12-50 beds), the median margin is 1.2%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 87 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MCHS-RED CEDAR (Target)WI25$123.4M16.8%
MERCY WALWORTH HOSPITALWI25$616.4M4.4%
ASPIRUS RIVERVIEW HOSPITAL & CWI44$161.3M13.1%
MEMORIAL MEDICAL CENTER INC.WI25$138.4M8.1%
LAKEVIEW MEDICAL CENTER OF RICWI40$137.4M-12.0%
MARSHFIELD MEDICAL CENTER-MINOWI19$129.6M-12.4%
FORT ATKINSON MEMORIAL HOSPITAWI49$127.0M-10.1%
MEMORIAL HOSPITAL OF BURLINGTOWI33$118.8M15.3%
OAK LEAF SURGICAL HOSPITAL LLCWI13$109.8M34.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $9.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.6M+210bp18mo
Cost to Collect4.5%2.5%$2.5M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.4M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.5M+122bp9mo
Clean Claim Rate88.0%96.0%$79K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.6M
Cost to Collect
$2.5M
Denial Rate Reduction
$2.4M
A/R Days Reduction
$1.5M
Clean Claim Rate
$79K
Total EBITDA Uplift$9.1M
Current EBITDA$20.7M
+ RCM Uplift+$9.1M
Pro Forma EBITDA$29.8M
Current Margin16.8%
Pro Forma Margin24.2%
WC Released (1x)$4.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$31.9M$227.7M7.13x48.1%
Base (11x exit)10.0x11.0x$31.9M$260.8M8.17x52.2%
Bull Case9.0x11.0x$28.7M$301.1M10.49x60.0%
Bull (12x exit)9.0x12.0x$28.7M$337.0M11.73x63.6%
Bear Case11.0x10.0x$35.1M$171.9M4.90x37.4%
Bear (11x exit)11.0x11.0x$35.1M$200.5M5.71x41.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 57.3% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 87 hospitals with 12-50 beds
  • Same-state prioritization (n=88)
  • Comp margins: P25=-10.1% / P50=1.2% / P75=8.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.